Gender (%) | |
Male to female ratio | 65.9:34.1 |
Age (years) | |
Mean (SD)/median | 65.2 (16.6)/66 |
Haemodynamic status on admission (%) | |
Normal (SBP ≥100 mm Hg and HR <100 bpm) | 57 |
Isolated tachycardia (HR ≥100 bpm) | 30 |
70 mm Hg ≥SBP<100 mm Hg | 11 |
50 mm Hg ≥SBP<70 mm Hg | 1 |
<50 mm Hg | 1 |
Admission haemoglobin (%) | |
>10 g/dL | 50 |
>8.0 g/dL ≤10 g/dL | 20.1 |
>7.0 g/dL ≤8.0 g/dL | 11.6 |
≤7.0 g/dL | 18.3 |
Mean (SD)/median (g/dL) | 10.3 (3.2)/10 |
Admission urea (%) | |
<3.0 mmol/dL | 3.0 |
≥3.0 mmol/dL <7.0 mmol/dL | 20.1 |
≥7.0 mmol/dL <12.0 mmol/dL | 29.0 |
≥12.0 mmol/dL <20 mmol/dL | 32.6 |
≥20.0 mmol/dL | 15.2 |
Mean (SD)/median (mmol/dL) | 12.7 (7.6)/11.3 |
Medication at presentation (%) | |
Aspirin | 34.5 |
Clopidogrel | 7.3 |
Oral anticoagulant | 8.5 |
Non-steroidal anti-inflammatory drug | 15.9 |
Proton pump inhibitor or H2 receptor antagonist | 37.2 |
Comorbidity at presentation (%) | |
Ischaemic heart disease | 16.8 |
Heart failure | 8.8 |
Malignancy | 9.8 |
Chronic kidney disease | 9.1 |
Chronic liver disease | 8.2 |
HR, heart rate; SBP, systolic blood pressure.